发明授权
- 专利标题： Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders
- 专利标题（中）： 用于治疗造血癌和增殖性疾病的固定药物比例
-
申请号： US12032583申请日： 2008-02-15
-
公开(公告)号： US08092828B2公开(公告)日： 2012-01-10
- 发明人: Arthur Louie , Christine Swenson , Lawrence Mayer , Andrew Janoff
- 申请人： Arthur Louie , Christine Swenson , Lawrence Mayer , Andrew Janoff
- 申请人地址： US NJ Princeton
- 专利权人： Celator Pharmaceuticals, Inc.
- 当前专利权人： Celator Pharmaceuticals, Inc.
- 当前专利权人地址： US NJ Princeton
- 代理机构： Morrison & Foerster LLP
- 主分类号： A61K9/127
- IPC分类号： A61K9/127 ; A61K31/00
摘要：
Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of cytarabine and an anthracycline. Such methods are particularly useful in the treatment of patients with advanced hematologic cancers or proliferative disorders.
公开/授权文献
信息查询
